Molecular imaging probes for 31P contrast

Molecular imaging probes for 31P contrast

<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...

Bibliografski detalji
Glavni autor:	Tear, L
Daljnji autori:	Faulkner, S
Format:	Disertacija
Jezik:	English
Izdano:	2018
Teme:	Contrast media (Diagnostic imaging) Nuclear magnetic resonance spectroscopy Gadolinium

Slični predmeti

Magnetic Resonance Imaging Contrast Agents: A Review of Literature
od: Zahra Sahraei, i dr.
Izdano: (2015-10-01)

Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
od: Marco Moscatelli, i dr.
Izdano: (2023-10-01)

Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
od: Johannes M. Froehlich, i dr.
Izdano: (2023-04-01)

Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines
od: Nacif Marcelo S, i dr.
Izdano: (2012-02-01)

Toxicity associated with gadolinium-based contrast-enhanced examinations
od: Silvia Maria Lattanzio
Izdano: (2021-05-01)

Нas the stability of gadoliniumbased magnetic resonance contrast media the clinical significance?
od: V. O. Panov, i dr.
Izdano: (2016-09-01)

Gadolinium Deposition in the Brain and Body
od: Aart J. van der Molen
Izdano: (2019-11-01)

Contrast‐Enhanced Cardiac Magnetic Resonance Imaging With a Manganese‐Based Alternative to Gadolinium for Tissue Characterization of Acute Myocardial Infarction
od: Benjamin P. Bonner, i dr.
Izdano: (2023-04-01)

Gadolinium retention after contrast-enhanced magnetic resonance imaging: A narrative review
od: Afnan Fahd Al-Muhanna
Izdano: (2022-01-01)

The safety of magnetic resonance imaging contrast agents
od: Amy Cunningham, i dr.
Izdano: (2024-08-01)

Novel MR imaging contrast agents for cancer detection
od: Daryoush Shahbazi-Gahrouei
Izdano: (2009-05-01)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
od: Jan M. Brendel, i dr.
Izdano: (2023-05-01)

THE USE OF INNOVATIVE DOMESTIC CONTRAST AGENT GADOLINIUM-BASED FOR MR-CANCER DIAGNOSIS IN EXPERIMENT
od: V. I. Chernov, i dr.
Izdano: (2016-02-01)

Choroid plexus volume in multiple sclerosis can be estimated on structural MRI avoiding contrast injection
od: Valentina Visani, i dr.
Izdano: (2024-02-01)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
od: Atiya Fatima, i dr.
Izdano: (2021-09-01)

Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection
od: Rong Lu, i dr.
Izdano: (2020-12-01)

The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances
od: Xiaodong Li, i dr.
Izdano: (2020-11-01)

Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
od: S A. Aleksandrova, i dr.
Izdano: (2024-12-01)

Dynamic nuclear polarisation as a probe of metabolism in pathophysiology
od: Miller, J
Izdano: (2015)

Gadolinium-Cyclic 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Click-Sulfonyl Fluoride for Probing Serine Protease Activity in Magnetic Resonance Imaging
od: Phuong Tu Huynh, i dr.
Izdano: (2023-04-01)

Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study
od: Jarl Åsbjørn Jakobsen, i dr.
Izdano: (2021-04-01)

Nephrogenic systemic fibrosis: Current concepts
od: Prasanta Basak, i dr.
Izdano: (2011-01-01)

MRI with Contrast Enhancement in a Patient with Chronic Kidney Disease: to Contrast Have Not Be Denied. Where Should We Put the Comma?
od: E. S. Kamyshova, i dr.
Izdano: (2019-03-01)

Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives
od: Bang J. Guo, i dr.
Izdano: (2018-09-01)

Fluorinated Paramagnetic Complexes: Sensitive and Responsive Probes for Magnetic Resonance Spectroscopy and Imaging
od: Katie L. Peterson, i dr.
Izdano: (2018-05-01)

Molecular Dynamics Simulations of the Internal Mobility of Gd3+-Based MRI Contrast Agents: Consequences for Water Proton Relaxivity
od: Alain Borel, i dr.
Izdano: (2004-04-01)

Absolute quantification of human in vivo hepatic 31P magnetic resonance spectroscopy at 7 tesla
od: Purvis, L
Izdano: (2018)

31P nuclear magnetic resonance study on binary germanium phosphate glasses /
od: 218458 Abdel Wahab Mohamed Ali Hussein, i dr.
Izdano: (2002)

Reducing contrast agent residuals in hospital wastewater: the GREENWATER study protocol
od: Moreno Zanardo, i dr.
Izdano: (2023-05-01)

Unusual Magnetic Resonance Imaging Findings Contrast-induced Encephalopathy following Cerebral Angiography
od: Won Ho Cho, i dr.
Izdano: (2021-12-01)

Intraindividual crossover comparison of gadobenate dimeglumine-enhanced and gadoxetate disodium-enhanced MRI for characterizing focal liver lesions
od: Wenjie Tang, i dr.
Izdano: (2025-02-01)

AI-powered contrast-free cardiovascular magnetic resonance imaging for myocardial infarction
od: Vedat Cicek, i dr.
Izdano: (2024-11-01)

A five-year-old boy with anaphylaxis reaction to gadolinium-based MR contrast medium: a case report
od: Seung Hun Woo, i dr.
Izdano: (2024-10-01)

Gadolinium-Coated Mesoporous Silica Nanoparticle for Magnetic Resonance Imaging
od: Zhongtao Li, i dr.
Izdano: (2022-02-01)

The Effectiveness of Calcium Supplement as Orally Contrast Media for Gastric Magnetic Resonance Imaging
od: Zainab Abdulla Mankhi, i dr.
Izdano: (2024-10-01)

Heavily Gd-Doped Non-Toxic Cerium Oxide Nanoparticles for MRI Labelling of Stem Cells
od: Anton L. Popov, i dr.
Izdano: (2023-01-01)

Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance
od: Neil Zaki, i dr.
Izdano: (2020-12-01)

Liver function assessment based on hepatobiliary contrast agent-enhanced magnetic resonance imaging
od: Sofiia F. Ageeva, i dr.
Izdano: (2024-09-01)

Contrast Medium Hypersensitivity: A Large Italian Study with Long-Term Follow-Up
od: Eleonora Nucera, i dr.
Izdano: (2022-03-01)

3D MR neurography with gadolinium contrast to improve the visualization of pelvic nerves and the branches
od: Hui Liu, i dr.
Izdano: (2024-05-01)